Day: April 27, 2021

NEWS RELEASE – REGULATED INFORMATION 27 April 2021, 7:00 a.m. CET IRVINE, CA, and HERSTAL, BELGIUM – 27 April 2021 – MDxHealth SA (Euronext Brussels: MDXH) (the “Company” or “MDxHealth“) a commercial-stage innovative molecular diagnostics company, today invites the holders of securities issued by the Company to its ordinary and extraordinary general shareholders’ meetings that will be held on Thursday 27 May 2021 at 10:00 a.m., Belgian time. The items on the agenda of the ordinary and extraordinary general shareholders’ meetings include the proposed approval of a number of resolutions relating to the financial year ended on 31 December 2020, as well as the issuance of a new share option plan called the “2021 Share Option Plan” and the renewal of the authorisation to the board of directors...

GHENT, Belgium, April 27, 2021 (GLOBE NEWSWIRE) — Sequana Medical NV (Euronext Brussels: SEQUA) (the “Company” or “Sequana Medical”), an innovator in the treatment of diuretic-resistant fluid overload in liver disease, malignant ascites and heart failure, today invites the holders of securities issued by the Company to attend the Annual and Extraordinary General Meetings of Shareholders on Thursday 27 May 2021. Furthermore, the annual report for the financial year 2020 has been published on Sequana Medical’s website and can be accessed here. The items on the agendas of the meetings include the proposed approval of a number of resolutions relating to the financial year ended on 31 December 2020, as well as the re-appointment of directors and the statutory auditor, the approval of a number of change of control...

COMMUNIQUÉ DE PRESSE – INFORMATION RÉGLEMENTÉE 27 avril 2021, 7h00 HEC  IRVINE, CA, et HERSTAL, BELGIQUE – le 27 avril 2021 – MDxHealth SA (Euronext Brussels: MDXH) (la “Société” ou “MDxHealth“), une société spécialisée dans le diagnostic moléculaire en phase de commercialisation, aujourd’hui invite les titulaires de titres émis par la Société à ses assemblées générales ordinaire et extraordinaire qui se tiendront le jeudi 27 mai 2021 à 10h00, heure belge. Les points à l’ordre du jour des assemblées générales ordinaire et extraordinaire des actionnaires comprennent, la proposition d’approbation d’un certain nombre de résolutions relatives à l’exercice social clos le 31 décembre 2020, ainsi que l’émission d’un nouveau plan de droits de souscription (share options) dénommé...

eQ Plc interim report27 April 2021 at 8:00 AM January to March 2021 in brief  The Group’s net revenue during the period was EUR 18.0 million (EUR 12.0 million from 1 Jan. to 31 March 2020). The Group’s net fee and commission income was EUR 15.8 million (EUR 11.7 million). The Group’s net investment income from own investment operations was EUR 2.2 million (EUR 0.3 million), including the return from private equity and real estate fund investments and liquid fixed income funds. The Group’s operating profit grew by 76% to EUR 10.6 million (EUR 6.0 million). The Group’s profit was EUR 8.4 million (EUR 4.8 million). The consolidated earnings per share were EUR 0.22 (EUR 0.13). The net revenue of the Asset Management segment grew by 31% to EUR 14.8 million (EUR 11.3 million) and the operating profit by 38% to EUR 8.8 million (EUR 6.4...

eQ Oyj:n osavuosikatsaus27.4.2021, klo 8:00 Tammi-maaliskuu 2021 lyhyestiKonsernin nettoliikevaihto oli kaudella 18,0 miljoonaa euroa (12,0 M€ 1.1.-31.3.2020). Konsernin nettopalkkiotuotot olivat 15,8 miljoonaa euroa (11,7 M€). Konsernin oman sijoitustoiminnan nettotuotot olivat 2,2 miljoonaa euroa (0,3 M€) sisältäen tuotot pääoma- ja kiinteistörahastosijoituksista sekä likvideistä korkorahastoista. Konsernin liikevoitto kasvoi 76 prosenttia ja oli 10,6 miljoonaa euroa (6,0 M€). Konsernin tulos oli 8,4 miljoonaa euroa (4,8 M€). Konsernin osakekohtainen tulos oli 0,22 euroa (0,13 euroa). Varainhoito-segmentin nettoliikevaihto kasvoi 31 prosenttia 14,8 miljoonaan euroon (11,3 M€) sekä liikevoitto 38 prosenttia 8,8 miljoonaan euroon (6,4 M€). Corporate Finance -segmentin nettoliikevaihto oli 1,1 miljoonaa euroa (0,4 M€) sekä liikevoitto...

Q1 net sales declined -2% (cc¹, +1% USD), due to prior year COVID-19 related forward purchasing (approximately USD 0.4 billion)Pharmaceuticals BU in line with prior year (0% cc, +4% USD) with continued strong growth from Entresto (+34% cc), Zolgensma (+81% cc), and Cosentyx (+11% cc). Kesimpta sales reached USD 50 million Oncology BU grew +1% (cc, +4% USD) driven by Kymriah (+55% cc), Promacta/Revolade (+13% cc), Kisqali (+19% cc) and Jakavi (+8% cc). Adakveo sales reached USD 37 million Sandoz sales declined -13% (cc, -9% USD), with Retail -18% (cc) and Biopharmaceuticals growing +7% (cc) COVID-19 negatively impacted demand, particularly: dermatology, ophthalmology, the breast cancer portfolio, Sandoz Retail and Anti-InfectivesExcluding prior year COVID-19 related forward purchasing, we estimate Q1 net sales grew +1% (cc, +4% USD),...

Company Announcement No. 881 DSV Panalpina A/S (“DSV”) has today signed an agreement to acquire Agility’s Global Integrated Logistics business (“GIL”), which is the global logistics division of Agility Public Warehousing Company K.S.C.P. (“Agility”). In 2020, GIL had USD 4.0 billion in revenue, of which approximately 80% is related to Air & Ocean freight, and approximately 17,000 employees. The acquisition will be an all-share transaction and closing is expected in the third quarter of 2021. DSV and Agility have reached an agreement that DSV will acquire GIL in an all-share transaction by issuing 19,304,348 shares of 1 DKK/share to Agility, representing approximately 8% of all post-transaction outstanding shares of DSV. This will make Agility the second largest shareholder based on today’s shareholder register. Based...

Norwegian energy and aluminum company Norsk Hydro ASA posted first-quarter underlying EBITDA of NOK 5,182 million, up from NOK 3,810 million in the same quarter last year. Strong global economic recovery boosted demand for renewable energy, aluminium and aluminium products. Hydro Energy and Hydro Extrusions business areas reported record quarterly results. * Strong demand drives recovery * Record EBITDA results in Extrusions and Energy * Improvement program ahead of plan * Agreement to sell Rolling, closing expected Q2-Q3 2021 * Investment decision for Alunorte fuel-switch project * Exploring hydrogen, other growth initiatives progressing Higher all-in metal prices, improved results from Energy and improved margins and volumes in Extrusions contributed positively to the result. These positive elements were partly offset by higher raw...

Energi- og aluminiumselskapet Norsk Hydro ASA rapporterte en underliggende EBITDA på 5.182 millioner kroner i første kvartal, noe som er en økning fra 3.810 millioner kroner i samme kvartal året før. En sterk oppgang i verdensøkonomien førte til økt etterspørsel etter fornybar energi, aluminium og aluminiumprodukter. Forretningsområdene Hydro Energy og Hydro Extrusions rapporterte rekordresultater for kvartalet.  * Høy etterspørsel bidrar til økonomisk gjeninnhenting * Rekordhøy EBITDA i Extrusions og Energy * Forbedringsprogrammet ligger foran skjema * Avtale om å selge Rolling, ventes gjennomført i andre eller tredje kvartal 2021 * Investeringsbeslutning i prosjektet for bytte av drivstoff ved Alunorte * Utforsking av hydrogen, andre vekstprosjekter fortsetter Høyere “all-in” metallpriser, bedre resultater fra Energy og bedre marginer...

LIVERMORE, Calif., April 27, 2021 (GLOBE NEWSWIRE) — FormFactor, Inc. (NASDAQ: FORM), a leading test and measurement supplier, was again ranked as the world’s number one supplier of semiconductor probe cards by market research firm VLSIresearch, after growing 18% in 2020. FormFactor has held the top position for eight consecutive years. FormFactor’s probe card revenues are primarily comprised of advanced wafer probe cards, a segment, which according to VLSIresearch, accounts for more than 85% of the overall probe card market. Key to the company’s success in 2020 was 40% revenue growth year-over-year in advanced probe cards used to test non-memory ICs. This growth was driven by Foundry and Logic customers as they ramped production of chipsets for 5G handsets, and accelerated adoption of advanced packaging techniques such as heterogenous...